US Stock MarketDetailed Quotes
EXAS Exact Sciences
- 52.910
- -0.160-0.30%
Close Nov 22 16:00 ET
- 52.810
- -0.100-0.19%
Pre 05:52 ET
9.79BMarket Cap-45612P/E (TTM)
54.260High52.790Low2.01MVolume53.320Open53.070Pre Close107.19MTurnover1.09%Turnover RatioLossP/E (Static)185.08MShares79.62052wk High3.05P/B9.72BFloat Cap40.62452wk Low--Dividend TTM183.72MShs Float159.540Historical High--Div YieldTTM2.77%Amplitude0.220Historical Low53.446Avg Price1Lot Size
About Exact Sciences Company
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Company Profile
SymbolEXAS
Company NameExact Sciences
Listing DateJan 31, 2001
Issue Price14.00
Founded1995
CEOMr. Kevin T. Conroy
MarketNASDAQ
Employees6600
Fiscal Year Ends12-31
Address5505 Endeavor Lane
CityMadison
ProvinceWisconsin
CountryUnited States of America
Zip Code53719
Phone1-608-284-5700
Websitehttp://www.exactsciences.com
Company Executives
- Name
- Position
- Salary
- Kevin T. Conroy
- Chairman of the Board, President and Chief Executive Officer
- 16.12M
- Aaron Bloomer
- Executive Vice President and Chief Financial Officer
- --
- Jacob Orville
- Executive Vice President and General Manager, Screening
- 3.67M
- Brian Baranick
- Executive Vice President and General Manager, Precision Oncology
- 3.57M
- James Herriott
- Senior Vice President, General Counsel and Secretary
- --
- Sarah Condella
- Executive Vice President, Human Resources
- --
- Scott D. Coward
- Director
- 1.47M
- Shacey Petrovic
- Independent Director
- 401.25K
- Daniel Joseph Levangie
- Independent Director
- 408.75K
- Michael J. Barber
- Independent Director
- --
- Kathleen Sebelius
- Independent Director
- 411.75K
- Katherine S. Zanotti
- Independent Director
- 406.25K
- Paul J. Clancy
- Independent Director
- 417.75K
- James E. Doyle
- Lead Independent Director
- 442.75K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
